Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye

British Journal of Ophthalmology

Volumn 87, Issue 1, 2003, Pages 54-56

  Horwath Winter, Jutta ^a   Bergloeff, J ^a   Floegel, I ^a   Haller Schober, E M ^a   Schmut, O ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ROSE BENGAL;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRY EYE; FEMALE; HUMAN; IMPRESSION CYTOLOGY; LACRIMAL FLUID; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIRMER TEST; STAINING; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; CONJUNCTIVA; DRY EYE SYNDROMES; EPITHELIUM; FEMALE; HUMANS; MALE; METAPLASIA; MIDDLE AGED; NEUROMUSCULAR AGENTS; TEARS;

EID: 0037235223     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.1.54     Document Type: Article

References (21)

1. Blasi J, Chapman ER, Link E. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993;365:160-3.
2. Price J, O'Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol 1993;13:67-71.
3. Kim JC, Chun JS, Hong RRS, et al. Delayed tear clearance induced by botulinum toxin injection in essential blepharospasm and hemifacial spasm. J Korean Ophthalmol Soc 1995;36:1084-92.
4. Shorr N, Seiff SR, Kopelman J. The use of botulinum toxin in blepharospasm. Am J Ophthalmol 1985;99:542-6.
5. Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sjögren's syndrome: A preliminary report. J Rheumatol 1997;24:1842-3.
6. Sahlin S, Chen E. Evaluation of the lacrimal drainage function by the drop test. Am J Ophthalmol 1996;122:701-8.
7. Lemp MA. Report of the national eye Institute: Industry workshop on clinical trials in dry eyes. CLAO J 1995;21:222-32.
8. Pflugfelder SC, Tseng SCG, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998;17:38-56.
9. Grandas F, Elston J, Quinn N, et al. Blepharospasm: A review of 264 patients. J Neurol Neurosurg Psychiatry 1988;51:767-72.
10. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997;75:281-6.
11. Van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969;82:10-14.
12. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985;92:728-33.
13. Anderson RL, Patel BCK, Holds JB, et al. Blepharospasm: Past, present, and future. Ophthal Plast Reconstr Surg 1998;14:305-17.
14. Tsubota K, Hata S, Okusawa Y, et al. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch Ophthalmol 1996;114:715-20.
15. Doane MG. Blinking and the mechanics of the lacrimal drainage system. Ophthalmology 1996;88:844-51.
16. Manning KA, Evinger C, Sibony PA. Eyelid movements before and after botulinum therapy in patients with lid spasm. Ann Neurol 1990;28:653-60.
17. Roggenkamper P, Laskawi R, Damenz W, et al. Changes in the blink reflex in patients with essential blepharospasm and hemifacial spasm. Fortschr Ophthalmol 1991;88:411-15.
18. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988;95:1529-34.
19. Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1 alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506-12.
20. Naumann M, Jost WH, Toyka KV. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999;56:914-16.
21. Odergren T, Hjaltason H, Kaakkola S, et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 1998;64:6-12.